Patient Support Services Contact Us
Image: Coherus Investors

Snapshot

Revenue & Earnings

Revenue (FY) $356.07
EBIT (Mil) (FY) $107.87
EBIT (Mil) (MRQ) $65.31
EBIT (Mil) (TTM) $203.15
EBITDA (Mil) (FY) $111.17
EBITDA (Mil) (MRQ) $66.06
EBITDA (Mil) (TTM) $206.40
Net Income Excluding Extraordinary Items (Mil) (FY) $89.83
Net Income Including Extraordinary Items (Mil) (FY) $89.83
Diluted EPS Excluding Extraordinary Items (FY) $1.23
Diluted EPS Including Extraordinary Items (FY) $1.23

Dividends

Yield (%) --
Dividend Record Date
Dividend Rate --%

Ratios

Price to Revenue (TTM) $2.80
Price to Revenue (MRQ) $2.50
Price to Revenue (FY) $3.83
Price To Cash Flow (TTM) $7.40
Price to Cash Flow (MRQ) $5.68
Price to Cash Flow (FY) $14.63
Price to Book (MRQ) $6.38
Price to Book (FY) $12.75
Total Debt to Equity (MRQ) (%) 189.10%
Total Debt to Equity (FY) (%) 169.55%
Current Ratio (MRQ) $5.21
Current Ratio (FY) $2.98

Growth

5-Year Annual Dividend Growth Rate (%) --%
5-Year Annual Revenue Growth Rate (%) 62.83%

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

Copyright Refinitiv